Skip to content
zameds

Lisinopril (Sinopren, Simayla Lisinopril, Lysin)

Lisinopril

Ranbaxy (SA) (Pty) Ltd

Registration

Applicant
Ranbaxy (SA) (Pty) Ltd
Certificate holder
Ranbaxy Pharmaceuticals (Pty) Ltd.
Registrations
8

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Sinopren 5 tablets

EACH TABLET CONTAINS LISINOPRIL 5,0 mg

5mg/10mg/20mgTablet.35020935/7.1.3/0209Approved 31 July 2021RegisteredNot determinedPIPIL
Sinopren 10 tablets

EACH TABLET CONTAINS LISINOPRIL 10,0 mg

5mg/10mg/20mgTablet.35021035/7.1.3/0210Approved 31 July 2021RegisteredNot determinedPIPIL
Sinopren 20 tablets

EACH TABLET CONTAINS LISINOPRIL 20,0 mg

5mg/10mg/20mgTablet.35021135/7.1.3/0211Approved 31 July 2021RegisteredNot determinedPIPIL
Simayla lisinopril 10

EACH TABLET CONTAINS LISINOPRIL 10,0 mg

1036011336/7.1.3/0113CancelledNot determinedNone
Simayla lisinopril 20

EACH TABLET CONTAINS LISINOPRIL 20,0 mg

2036011436/7.1.3/0114CancelledNot determinedNone
Lysin 5

EACH TABLET CONTAINS LISINOPRIL 5,0 mg

541011641/7.1.3/0116CancelledNot determinedNone
Lysin 10

EACH TABLET CONTAINS LISINOPRIL 10,0 mg

1041011741/7.1.3/0117CancelledNot determinedNone
Lysin 20

EACH TABLET CONTAINS LISINOPRIL 20,0 mg

2041011841/7.1.3/0118CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S3: Hydrochlorothiazide

    Consolidated Schedules 06 July 2026, line 3721

  • S3: Lisinopril

    Consolidated Schedules 06 July 2026, line 3902

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C21H31N3O5405.50 g/mol

(2S)-1-[(2S)-6-Amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid

Drag to rotate. Structure from PubChem CID 5362119.

SAHPRA documents

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles